Using relative utility curves to evaluate risk prediction

Journal of the Royal Statistical Society. Series A: Statistics in Society

Volumn 172, Issue 4, 2009, Pages 729-748

  Baker, Stuart G ^a   Cook, Nancy R ^b   Vickers, Andrew ^c   Kramer, Barnett S ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Decision analysis; Decision curve; Receiver operating characteristic curve; Utility

Indexed keywords

EID: 67650046515     PISSN: 09641998     EISSN: 1467985X     Source Type: Journal    
DOI: 10.1111/j.1467-985X.2009.00592.x     Document Type: Article

References (17)

1. Adams, N. M. Hand, D. J. (1999) Comparing classifiers when the misallocation costs are uncertain. Pattn Recogn, 32, 1139 1147.
2. Briggs, W. M. Zaretski, R. (2008) The skill plot: a graphical technique for evaluating continuous diagnostic tests. Biometrics, 64, 250 256.
3. Cook, N. R. (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation, 115, 928 935.
4. Gail, M. H. Pfeiffer, R. M. (2005) On criteria for evaluating models for absolute risk. Biostatistics, 6, 227 239.
5. Greenhouse, S. W. Mantel, N. (1950) The evaluation of diagnostic tests. Biometrics, 6, 399 412.
6. Greenland, S. (2008) The need for reorientation toward cost-effective prediction: comments on ''Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond'' by M. J. Pencina et al. Statist. Med., 27, 199 206 correction, 316.
7. Heagerty, P. J., Lumley, T. Pepe, M. S. (2000) Time-dependent ROC curve for censored survival data and a diagnostic marker. Biometrics, 56, 337 334.
8. Huang, Y., Pepe, M. S. Feng, Z. (2007) Evaluating predictiveness of a continuous marker. Biometrics, 63, 1181 1188.
9. Metz, C. E. (1978) Basic principles of ROC analysis. Sem. Nucl. Med., 8, 283 298.
10. Michiels, S., Koscielny, S. Hill, C. (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet, 365, 488 492. (Pubitemid 40215731)
11. Pauker, S. G. Kassirer, J. P. (1975) Therapeutic decision making: a cost-benefit analysis. New Engl. J. Med., 293, 229 234.
12. Peirce, C. S. (1884) The numerical measure of the success of predictions. Science, 4, 453 454.
13. Pencina, M. J., D'Agostino, Sr., R. B., D'Agostino, Jr., R. B. Vasan, R. S. (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statist. Med., 27, 157 172.
14. Ransahoff, D. F. Feinstein, A. R. (1978) Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. New Engl. J. Med., 299, 926 930.
15. Ridker, P. M., Cook, N. R., Lee, I. M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H. Buring, J. E. (2005) A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. New Engl. J. Med., 352, 1293 1304.
16. Vickers, A. J. Elkin, E. B. (2006). Decision curve analysis: a novel method for evaluating prediction models. Med. Decsn Makng, 26, 565 574.
17. Weinstein, M. C., Fineberg, H. V., Elstein, A. S., Frazier, N. S., Neuhauser, D., Neutra, R. R. McNeil, B. J. (1980) Clinical Decision Analysis. Philadelphia : Saunders.